AACR Policy Webinars
Keep up to date on the various policy issues that are important to the AACR and learn how you can become an advocate for medical research funding and for various AACR initiatives with these webinars.
In recognition of the FDA ban on e-cigarette sales to youth, which took effect in August, the AACR Tobacco and Cancer subcommittee released a new webinar featuring key experts who will present current research on, and the public health impact of, e-cigarettes.
The State of ENDS Science
Electronic nicotine delivery systems (ENDS), which include electronic cigarettes (e-cigarettes) have become increasingly popular among adults and youth and have been suggested as potential tobacco cessation products. In this webinar, our panel of experts will provide an updated state of knowledge about the safety and efficacy of ENDS from a scientific research standpoint.
The Importance of Local Advocacy for Medical Research
Advocacy often conjures images of traveling to Washington, D.C., and meeting with members of Congress and their staff on Capitol Hill. But there are plenty of ways to be active at the local level as well. View this webinar to learn about the importance of advocacy activities during the August Congressional recess and hear how through local district meetings,town halls, and other activities, you can become an advocate for medical research at the local level.
Becoming an Advocate for Medical Research
No one understands the constraints of decreased federal funding as well as researchers themselves. Many cancer researchers, particularly early career investigators, understand the importance of advocating for science and funding, yet the demands of starting and running a lab often mean that advocacy activities get left behind. How do you get started in advocacy, and how do you craft your message into one that will resonate with Congress Watch our webinar on medical research advocacy and find out the answers to those questions and more.
FDA’s Proposed Framework for Regulating Laboratory-developed Tests
On Dec. 17, 2014, the AACR hosted a webinar presented by the FDA, in which they gave an overview of their proposed LDT guidelines and took questions from the audience.